凯信远达

$凯信远达(CASI)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001104659-25-120162  Act: 34  Size: 31 KB 网页链接

$凯信远达(CASI)$ SCHEDULE 13D/A [Amend] General Statement of Acquisition of Beneficial Ownership Accession Number: 0001193125-25-322768  Act: 34  Size: 12 KB 网页链接

$凯信远达(CASI)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001104659-25-124228  Act: 34  Size: 46 KB 网页链接

$凯信远达(CASI)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001104659-25-113974  Act: 34  Size: 38 KB 网页链接

$凯信远达(CASI)$ D Notice of Exempt Offering of Securities, item 06b Accession Number: 0001962738-26-000001  Act: 33  Size: 17 KB 网页链接

$凯信远达(CASI)$ SCHEDULE 13D/A [Amend] General Statement of Acquisition of Beneficial Ownership Accession Number: 0001104659-25-122209  Act: 34  Size: 18 KB 网页链接

$凯信远达(CASI)$ SCHEDULE 13D/A [Amend] General Statement of Acquisition of Beneficial Ownership Accession Number: 0001104659-26-008171  Act: 34  Size: 79 KB 网页链接

$凯信远达(CASI)$ SCHEDULE 13D/A [Amend] General Statement of Acquisition of Beneficial Ownership Accession Number: 0001104659-26-002272  Act: 34  Size: 42 KB 网页链接

1月16日，凯信远达（CASI）宣布，其抗CD38单抗CID-103用于治疗活动性和慢性活动性同种异体肾移植抗体介导的排斥反应（AMR）的临床试验申请（CTA）获中国国家药品监督管理局（NMPA）批准。该I/II期临床试验为剂量探索及安全性研究，旨在评估CID-103在肾移植AMR成人患者中的耐受性与疗效。
CID-1...

$凯信远达(CASI)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0001104659-26-015415  Act: 34  Size: 11 KB 网页链接

$凯信远达(CASI)$ SCHEDULE 13D/A [Amend] General Statement of Acquisition of Beneficial Ownership Accession Number: 0000929638-26-000185  Act: 34  Size: 17 KB 网页链接

$凯信远达(CASI)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001104659-26-012391  Act: 34  Size: 13 KB 网页链接

$凯信远达(CASI)$ SCHEDULE 13D/A [Amend] General Statement of Acquisition of Beneficial Ownership Accession Number: 0001104659-26-012278  Act: 34  Size: 80 KB 网页链接

$凯信远达(CASI)$ SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors Accession Number: 0001104659-25-116430  Act: 34  Size: 5 KB 网页链接

$凯信远达(CASI)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001104659-25-125300  Act: 34  Size: 14 KB 网页链接

$凯信远达(CASI)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001104659-26-005647  Act: 34  Size: 14 KB 网页链接

$凯信远达(CASI)$ SCHEDULE 13D/A [Amend] General Statement of Acquisition of Beneficial Ownership Accession Number: 0000929638-26-000184  Act: 34  Size: 57 KB 网页链接

$凯信远达(CASI)$ D Notice of Exempt Offering of Securities, item 06b Accession Number: 0001962738-26-000002  Act: 33  Size: 17 KB 网页链接

$凯信远达(CASI)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001104659-26-003118  Act: 34  Size: 14 KB 网页链接